1. Home
  2. SCLX vs AEON Comparison

SCLX vs AEON Comparison

Compare SCLX & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$0.57

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.12

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
AEON
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
13.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SCLX
AEON
Price
$0.57
$0.12
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $1.82
AVG Volume (30 Days)
73.1K
★ 809.4K
Earning Date
12-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
N/A
Revenue This Year
$118.16
N/A
Revenue Next Year
$186.31
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.54
$0.11
52 Week High
$23.03
$1.45

Technical Indicators

Market Signals
Indicator
SCLX
AEON
Relative Strength Index (RSI) 8.42 29.39
Support Level N/A N/A
Resistance Level $7.77 $0.33
Average True Range (ATR) 0.17 0.03
MACD -0.04 -0.01
Stochastic Oscillator 2.80 10.50

Price Performance

Historical Comparison
SCLX
AEON

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: